starpharma | home
home
about starpharma
technology
product pipeline
news room
investor relations
careers contact us
site search

Analyst Reports
 
 

Bioshares Issue 363: SPL: Five Stocks to accumulate in the Weakened Market
21/06/2010

Current Analyst Valuations and Price Targets
29/04/2010

Bioshares Issue 342: Stock Picks - 2010
22/12/2009

Bioshares Issue 337: Starpharma Seeks New Product Opportunity for Vivagel
16/11/2009

Bioshares Issue 322: Biotech Divide Continues
4/08/2009

Bioshares Issue 311: Stellar Performance by Leading Australian Biotech Stocks for Start of 2009
18/05/2009

Bioshares Issue 280: Starpharma Secures Major Licensing Deal
15/09/2008

Bioshares Issue 265: Starpharma's International Investor Appeal
6/06/2008

Standard & Poor's Stock Report (Updated Regularly)

 Archive

2007

2006

Please note that any opinions, estimates or forecasts regarding Starpharma's performance made by analysts mentioned on this website are theirs alone and do not represent opinions, forecasts or predictions of Starpharma or its management. Starpharma does not by its reference to any analysts imply its endorsement of or concurrence with their information, conclusions, or recommendations. Information provided by analysts is subject to change, and Starpharma cannot guarantee its accuracy.